[Complications of antitumor and antileukemic chemotherapy. 1].
The recent development of chemotherapy in the treatment of cancer and leukemia requires that all practitioners involved have a thorough knowledge of the sometimes life-threatening side-effects of chemotherapeutic agents. All these agents, whether used alone or in a combination, carry a risk because of their lack of specificity which make active on normal cells, especially those with a rapid turn-over such as the hematopoietic cells or the cells of the digestive tract. Prior to the prescription of a chemotherapeutic regimen, the acceptable risk must always be clearly defined, according to the seriousness of the disease and to the patient's age, physical condition and psychological status. During the course continuous monitoring adjusted to the specific toxicity of the agents used is requisite. More or less prominent asthenia and weight loss are common, as the result of various physiopathological mechanisms. Digestive disorders may consist only of nausea and emesis or include mucosal lesions with diarrhea as the main feature. Vincristine and vindesine are responsible for constipation. Hepatic toxicity, which is less common, is usually due to L-asparaginase. Transient hair loss is the most frequent cutaneous side-effect. Hyperpigmentation, photosensitivity, nail lesions, cellulitis and ulcerations may occur, as well as specific lesions with bleomycin. High fever during injection often occurs with this last agent.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D004066:Digestive System Diseases / Q000139:chemically induced; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D012306:Risk; D012871:Skin Diseases / Q000139:chemically induced
D000970:Antineoplastic Agents
Accidents de la chimiothérapie antitumorale et antileucémique. Première partie.